Foghorn Therapeutics (FHTX) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Foghorn Therapeutics (FHTX) over the last 6 years, with Q3 2025 value amounting to 0.11.
- Foghorn Therapeutics' Asset Utilization Ratio rose 4194.59% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 4194.59%. This contributed to the annual value of 0.08 for FY2024, which is 1978.66% down from last year.
- Per Foghorn Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.11 for Q3 2025, which was up 4194.59% from 0.1 recorded in Q2 2025.
- Foghorn Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.13 during Q1 2024, with a 5-year trough of 0.0 in Q1 2021.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.06 (2023), whereas its average is 0.06.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 112667.99% in 2022, then crashed by 3304.49% in 2024.
- Over the past 5 years, Foghorn Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then surged by 1126.68% to 0.05 in 2022, then soared by 148.61% to 0.11 in 2023, then tumbled by 33.04% to 0.08 in 2024, then skyrocketed by 49.02% to 0.11 in 2025.
- Its Asset Utilization Ratio stands at 0.11 for Q3 2025, versus 0.1 for Q2 2025 and 0.09 for Q1 2025.